About Us

Optolytics had its origin in 1992 when we began to study portable devices to measure psychometric values to assess the degree of cognitive stimulation or sedation from medication.  Research involved measuring critical flicker fusion in Parkinson’s Disease and patients using narcotic medication. Today, Optolytics’ goal is to develop a mobile device application to quickly assess concussions in athletes on the field. 

Leadership

Richard L. Peatman, Pharm.D., was born and grew up in California.  He did undergraduate work at  U.C.L.A. and received a Doctor of Pharmacy degree from U.S.C.  His experience includes work for the Dept. of Cardiothoracic Surgery at U.C.L.A., Methodist Hospital of Sacramento and over 3 decades of private pharmacy practice.  He is passionate about developing practical diagnostic applications for devices that can be inexpensively and conveniently used by coaches, trainers, and medical personnel immediately after a potential injury.